Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer (Q33255024)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer |
scientific article |
Statements
1 reference
Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer (English)
1 reference
Qing-an Yuan
1 reference
Heidi H Simmons
1 reference
Matthew K Robinson
1 reference
Maria Russeva
1 reference
Wayne A Marasco
1 reference
Gregory P Adams
1 reference
1 August 2006
1 reference
1 reference
2096-2105
1 reference
Identifiers
1 reference
1 reference